Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

about

MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.

P2860

Q33912016-A97FF37B-8976-4F56-804C-AF65927BBF68 Q50224580-FB15BD64-BACF-4606-8E57-F4C8B214E813

P2860

Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

Item

http://www.wikidata.org/entity/Q39097822

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

@en

Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

@nl

type

Item

label

Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

@en

Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

@nl

prefLabel

Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

@en

Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

@nl

P1476

Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

@en

P2093

Andrey Z Vinarov

http://www.w3.org/2001/XMLSchema#string

Marina O Golovastova

http://www.w3.org/2001/XMLSchema#string

Pavel P Philippov

http://www.w3.org/2001/XMLSchema#string

Vladimir A Varshavsky

http://www.w3.org/2001/XMLSchema#string

Wan-Hai Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Human pyruvate kinase M2: a multifunctional protein

Renal cell carcinoma: histological classification and correlation with imaging findings

Molecular marker for predicting treatment response in advanced renal cell carcinoma: does the promise fulfill clinical need?

Renal tumors: diagnostic and prognostic biomarkers

Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma.

Cancer statistics, 2015

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

Tetravalent antibody-scTRAIL fusion proteins with improved properties.

Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma.

Urinary biomarkers for the early diagnosis of kidney cancer.

P2888

s11934-017-0655-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11934-017-0655-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28110463

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

about

P2860

P2860

Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921